These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28922189)

  • 1. ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders.
    Subramaniam RM; Frey KA; Hunt CH; Mercier GA; Solnes LB; Colletti PM; Lu Y; Savir-Baruch B; Williams HT
    Clin Nucl Med; 2017 Nov; 42(11):847-852. PubMed ID: 28922189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of DAT-SPECT in movement disorders.
    Kägi G; Bhatia KP; Tolosa E
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):5-12. PubMed ID: 20019219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients.
    Plotkin M; Amthauer H; Klaffke S; Kühn A; Lüdemann L; Arnold G; Wernecke KD; Kupsch A; Felix R; Venz S
    J Neural Transm (Vienna); 2005 May; 112(5):677-92. PubMed ID: 15375677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders.
    Akdemir ÜÖ; Bora Tokçaer A; Atay LÖ
    Turk J Med Sci; 2021 Apr; 51(2):400-410. PubMed ID: 33237660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal dopamine transporter binding differs between dementia with Lewy bodies and Parkinson's disease with dementia.
    Ishizawa K; Fujita Y; Nagashima K; Nakamura T; Shibata M; Kasahara H; Makioka K; Taketomi-Takahashi A; Hirasawa H; Higuchi T; Tsushima Y; Ikeda Y
    J Neurol Sci; 2023 Aug; 451():120713. PubMed ID: 37441875
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.
    Booth TC; Nathan M; Waldman AD; Quigley AM; Schapira AH; Buscombe J
    AJNR Am J Neuroradiol; 2015 Feb; 36(2):236-44. PubMed ID: 24924549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter SPECT imaging in Parkinson's disease and atypical Parkinsonism: a study of 137 patients.
    Constantinides VC; Souvatzoglou M; Paraskevas GP; Chalioti M; Stefanis L; Kapaki E
    Neurol Sci; 2023 May; 44(5):1613-1623. PubMed ID: 36658411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism.
    Hastings A; Cullinane P; Wrigley S; Revesz T; Morris HR; Dickson JC; Jaunmuktane Z; Warner TT; De Pablo-Fernández E
    Neurology; 2024 Jun; 102(11):e209453. PubMed ID: 38759132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of dopamine transporter single photon emission computed tomography imaging using I-123 ioflupane on diagnoses of patients with parkinsonian syndromes.
    Bairactaris C; Demakopoulos N; Tripsianis G; Sioka C; Farmakiotis D; Vadikolias K; Heliopoulos I; Georgoulias P; Tsougos I; Papanastasiou I; Piperidou C
    J Clin Neurosci; 2009 Feb; 16(2):246-52. PubMed ID: 19097795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal Familial Insomnia Initially Developing Parkinsonism Mimicking Dementia with Lewy Bodies.
    Fukuoka T; Nakazato Y; Yamamoto M; Miyake A; Mitsufuji T; Yamamoto T
    Intern Med; 2018 Sep; 57(18):2719-2722. PubMed ID: 29709939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
    Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
    Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective and efficient diagnosis of parkinsonism: the role of dopamine transporter SPECT imaging with ioflupane I-123 injection (DaTscan™).
    Cummings JL; Fine MJ; Grachev ID; Jarecke CR; Johnson MK; Kuo PH; Schaecher KL; Oberdorf JA; Rezak M; Riley DE; Truong D
    Am J Manag Care; 2014 Mar; 20(5 Suppl):S97-109. PubMed ID: 24773455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes.
    Chen QS; Li XY; Li L; Lu JY; Sun YM; Liu FT; Zuo CT; Wang J
    Acta Neurol Scand; 2022 Sep; 146(3):237-245. PubMed ID: 35611608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
    Seppi K; Scherfler C; Donnemiller E; Virgolini I; Schocke MF; Goebel G; Mair KJ; Boesch S; Brenneis C; Wenning GK; Poewe W
    Arch Neurol; 2006 Aug; 63(8):1154-60. PubMed ID: 16908744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice.
    Ba F; Martin WR
    Parkinsonism Relat Disord; 2015 Feb; 21(2):87-94. PubMed ID: 25487733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT.
    Takaya S; Sawamoto N; Okada T; Okubo G; Nishida S; Togashi K; Fukuyama H; Takahashi R
    Parkinsonism Relat Disord; 2018 Feb; 47():15-21. PubMed ID: 29157745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.
    Van Laere K; Casteels C; De Ceuninck L; Vanbilloen B; Maes A; Mortelmans L; Vandenberghe W; Verbruggen A; Dom R
    J Nucl Med; 2006 Mar; 47(3):384-92. PubMed ID: 16513606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Antonini A; Benti R; De Notaris R; Tesei S; Zecchinelli A; Sacilotto G; Meucci N; Canesi M; Mariani C; Pezzoli G; Gerundini P
    Neurol Sci; 2003 Oct; 24(3):149-50. PubMed ID: 14598060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the Diagnosis of Parkinsonian Syndromes With
    Banks KP; Peacock JG; Clemenshaw MN; Kuo PH
    AJR Am J Roentgenol; 2019 Aug; 213(2):243-253. PubMed ID: 30995085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.